Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease
Md. Sahab Uddin, Sharifa Hasana, Jamil Ahmad, et al.
Current Pharmaceutical Design (2020) Vol. 27, Iss. 3, pp. 402-414
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab
Mingchao Shi, Fengna Chu, Feiqi Zhu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 189
Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer’s Disease
Fahadul Islam, Jannatul Fardous Khadija, Md. Harun-Or-Rashid, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 59
Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
Ping Liu, Yunyun Wang, Yan Sun, et al.
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 665-674
Open Access | Times Cited: 54
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 745-766
Closed Access | Times Cited: 54
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 33
Morin protects against acrylamide-induced neurotoxicity in rats: an investigation into different signal pathways
Cihan Gür, Fatih Mehmet Kandemir, Ekrem Darendelioğlu, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 36, pp. 49808-49819
Closed Access | Times Cited: 52
Th1/Th2 imbalance and heat shock protein mediated inflammatory damage triggered by manganese via activating NF-κB pathway in chicken nervous system in vivo and in vitro
Zhiying Miao, Kun Zhang, Rongkun Bao, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 32, pp. 44361-44373
Closed Access | Times Cited: 44
Protective effect of irisin against Alzheimer’s disease
Kang Chen, Kun Wang, Tianhui Wang
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 25
The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease
Ancuța-Veronica Lupăescu, Monica Iavorschi, Mihai Covașă
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 235-235
Open Access | Times Cited: 23
Neolignans in Magnolia officinalis as natural anti-Alzheimer’s disease agents: A systematic review
Na Li, Yuanyuan Liang, Lijuan Zhang, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102398-102398
Closed Access | Times Cited: 5
Role of Plant-Derived Compounds in the Molecular Pathways Related to Inflammation
Agata J. Olędzka, Monika E. Czerwińska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4666-4666
Open Access | Times Cited: 12
RETRACTED: Hesperidin methylchalcone (HMC) hinders amyloid-β induced Alzheimer's disease by attenuating cholinesterase activity, macromolecular damages, oxidative stress and apoptosis via regulating NF-κB and Nrf2/HO-1 pathways
Zhuo Wang, Chao Gao, Lei Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 233, pp. 123169-123169
Open Access | Times Cited: 11
Ginger leaf polyphenols mitigate β-amyloid toxicity via JNK/FOXO pathway activation in Caenorhabditis elegans
Tao Gao, Ningning Yan, Y. N. Pu, et al.
Food & Function (2025)
Closed Access
Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
Dan Chen, Yun Sun
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 1
Open Access
Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer’s Disease
Éva Kiss, Stefan Kins, Karin Gorgas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4165-4165
Open Access | Times Cited: 3
Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
A. Tolédano, Arantxa Rodríguez‐Casado, María‐Isabel Álvarez, et al.
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1101-1101
Open Access | Times Cited: 3
Neuroimmune disruptions from naturally occurring levels of mycotoxins
Sara Shahba, Jalil Mehrzad, Amir Mohammad Malvandi
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 25, pp. 32156-32176
Closed Access | Times Cited: 23
Boswellia serrata suppress fipronil-induced neuronal necrosis and neurobehavioral alterations via promoted inhibition of oxidative/inflammatory/apoptotic pathways
Asmaa F. Khafaga, Sara E. El-Kazaz, Ahmed E. Noreldin
The Science of The Total Environment (2021) Vol. 785, pp. 147384-147384
Closed Access | Times Cited: 22
Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer’s Disease
Md. Sohanur Rahman, Md. Sahab Uddin, Md. Ataur Rahman, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 4017-4029
Closed Access | Times Cited: 22
Downregulation of oxidative stress-mediated glial innate immune response suppresses seizures in a fly epilepsy model
Krishna Madhav Nukala, Anthony J. Lilienthal, Shu Hui Lye, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 112004-112004
Open Access | Times Cited: 8
Minocycline effects on memory and learning impairment in the beta-amyloid-induced Alzheimer’s disease model in male rats using behavioral, biochemical, and histological methods
Zahra Gholami Mahmoudian, Ali Ghanbari, Iraj Rashidi, et al.
European Journal of Pharmacology (2023) Vol. 953, pp. 175784-175784
Closed Access | Times Cited: 8
Over the Counter Supplements for Memory: A Review of Available Evidence
Haley Hersant, Sean He, Peter Maliha, et al.
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 797-817
Closed Access | Times Cited: 8
Epigenetic regulation of synaptic disorder in Alzheimer’s disease
Zhiying Chen, Moxin Wu, Qin Lai, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top